PlainPharmaWatch

CMS Open Payments · Program Year 2024

Aesculap Implant Systems, LLC

Aesculap Implant Systems, LLC reported $670,398.37 in payments to 222 physicians and teaching hospitals across 222 transactions.

See the rankings → How this is sourced
$670.4K
Total payments
222
Transactions
222
Recipients
−$100.5K
General Payments vs PY2023

Aesculap Implant Systems, LLC reported $670,398.37 in payments to 222 physicians and teaching hospitals in CMS Open Payments Program Year 2024 - ranking #702 of 1,925 reporting manufacturers (0.0% of all US industry payments), averaging $3.0K per recipient across 6 payment categories. Figures are company-reported under the Physician Payments Sunshine Act; a reported payment is a financial relationship, not evidence of wrongdoing.

Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.

Compiled from official public sources by the editorial team.

The verdict

Aesculap Implant Systems, LLC pairs above-median payment volume with a moderately concentrated payment pattern.

#702
of 1,925 companies
0.0%
of all US industry payments
0.4%
paid to its single top recipient
6
payment categories

Release-over-release change

General Payments changed from PY2023 to PY2024

Aesculap Implant Systems, LLC's CMS-reported General Payments decreased by $100.5K (−13.0%) from PY2023 to PY2024. The comparison uses the same CMS manufacturer-by-payment-category summary for both years and excludes research and ownership or investment records.

CMS source labels for this exact identifier: PY2022: AESCULAP IMPLANT SYSTEMS, LLCPY2023: AESCULAP IMPLANT SYSTEMS, LLCPY2024: Aesculap Implant Systems, LLC. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.

Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.

General Payments: PY2023 vs PY2024

Annual CMS-reported totals for this company, not an all-category Open Payments total

PY2023$770.9KPY2024$670.4K
PY2023
$770,939.06
PY2024
$670,398.37

How Aesculap Implant Systems, LLC ranks nationally

Where this company's total reported payments fall within the full national distribution of all 1,925 companies in CMS Open Payments, not just its nearest peers.

Aesculap Implant Systems, LLC's total vs. every reporting company

CMS Open Payments, Program Year 2024

$670,398 Top 36% higher than 64% of 1,925 reporting companies

$9–$28: 3 reporting companies (0%). Below this entry. $28–$87: 10 reporting companies (1%). Below this entry. $87–$270: 20 reporting companies (1%). Below this entry. $270–$838: 41 reporting companies (2%). Below this entry. $838–$2,603: 76 reporting companies (4%). Below this entry. $2,603–$8,084: 114 reporting companies (6%). Below this entry. $8,084–$25,112: 167 reporting companies (9%). Below this entry. $25,112–$78,003: 249 reporting companies (13%). Below this entry. $78,003–$242,294: 295 reporting companies (15%). Below this entry. $242,294–$752,621: 270 reporting companies (14%). This entry sits in this band. $752,621–$2,337,813: 263 reporting companies (14%). Above this entry. $2,337,813–$7,261,783: 200 reporting companies (10%). Above this entry. $7,261,783–$22,556,757: 133 reporting companies (7%). Above this entry. $22,556,757–$70,066,439: 45 reporting companies (2%). Above this entry. $70,066,439–$217,642,369: 26 reporting companies (1%). Above this entry. $217,642,369–$676,046,922: 13 reporting companies (1%). Above this entry. This company $9 $676,046,922 every reporting company, bucketed by value

Each bar is a progressively wider band; taller bars hold more reporting companies. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Open Payments · 2024

What the Data Shows for Aesculap Implant Systems, LLC

$670,398.37: that is what Aesculap Implant Systems, LLC reported in payments to 222 physicians and teaching hospitals during Program Year 2024, spread across 222 transactions ($3.0K per transaction, $3.0K per recipient). The company sits at rank #702 of 1,925, a comparatively small 0.0% slice of all industry payments reported nationwide for the year.

"Royalty or License" leads the 6-category general-payment breakdown below at $352.6K (52.6% of the company's reported total, 17 transactions) - see our methodology for how research and ownership payments are reported separately.

General Payment Breakdown by Type

Across 6 types of general payments, Aesculap Implant Systems, LLC's largest category was "Royalty or License" at $352.6K - 52.6% of the company's reported total.

How Aesculap Implant Systems, LLC divides its payments

How the reported total splits across payment categories

1. Royalty or License$352.6K2. Debt Forgiveness$198.0K3. Consulting Fee$83.3K4. Travel and Lodging$22.5K5. Space Rental or Facility …$8.7K6. Food and Beverage$5.3K
Payment Type Amount Transactions
Royalty or License $352.6K 17
Debt Forgiveness $198.0K 24
Consulting Fee $83.3K 23
Travel and Lodging $22.5K 71
Space Rental or Facility Fees $8.7K 1
Food and Beverage $5.3K 86

Recipient Concentration in General Payments

The five largest recipient relationships account for $409,200.06 (61.0%) of $670,398.37 in this company's General Payments records across 81 recipients. This is a CMS Open Payments Program Year 2024 General Payments view only: it excludes research and ownership/investment records, so it is not the all-category company total above.

Largest General-Payment relationships for Aesculap Implant Systems, LLC

The five named recipients with the highest reported General Payments from this company

Roger Jackson$253.3KJeffrey Kozak$50.7KJack Zigler$37.1KNortheast Georgia Medical Ce…$36.3KNorman Regional Hospital Aut…$31.9K
  1. 1

    Roger Jackson

    $253,265.19 across 4 reported transactions

  2. 2

    Jeffrey Kozak

    $50,653.92 across 4 reported transactions

  3. 3

    Jack Zigler

    $37,103.95 across 23 reported transactions

  4. 4

    Northeast Georgia Medical Center

    $36,292.00 across 1 reported transactions

  5. 5

    Norman Regional Hospital Authority

    $31,885.00 across 1 reported transactions

Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.

Payment Size Analysis

Average transaction size: $3.0K. Average per recipient: $3.0K.

Total Amount

$670,398.37

Avg per Transaction

$3.0K

Avg per Recipient

$3.0K

Payment Transparency Context

What is the Sunshine Act?

The Physician Payments Sunshine Act (part of the Affordable Care Act) requires pharmaceutical and medical device manufacturers to report payments and transfers of value to physicians and teaching hospitals. These payments can include consulting fees, research grants, speaker fees, food and beverages, travel, royalties, and other forms of compensation.

Industry Total (2024)

$13.9B

across 1,925 companies

Aesculap Implant Systems, LLC Share

0.0%

#702 by total payments

Companies with Similar Payment Volumes

Pharmaceutical companies with payment totals similar to Aesculap Implant Systems, LLC

Teleflex Incorporated

$670.6K 117 recipients

Vascular Graft Solutions Inc

$668.1K 2 recipients

Verathon Inc.

$672.8K 134 recipients

Extremity Medical

$672.9K 438 recipients

Synapse Surgical LLC

$674.2K 0 recipients

Xtant Medical Inc

$659.3K 454 recipients

Frequently Asked Questions

How much did Aesculap Implant Systems, LLC pay to physicians and hospitals in 2024? ▾
Aesculap Implant Systems, LLC made $670,398.37 in payments to physicians and hospitals in Program Year 2024, across 222 individual transactions. This represents 0.0% of all industry payments reported to CMS Open Payments.
How many physicians received payments from Aesculap Implant Systems, LLC? ▾
Aesculap Implant Systems, LLC made payments to 222 physicians and teaching hospitals in 2024. The average payment per recipient was $3.0K.
What types of payments did Aesculap Implant Systems, LLC make? ▾
General payments from Aesculap Implant Systems, LLC span 6 distinct categories, covering things like consulting, meals, and travel. The largest general-payment category was "Royalty or License" at $352.6K, representing 52.6% of the company's reported total.
How does Aesculap Implant Systems, LLC rank among pharmaceutical companies? ▾
Aesculap Implant Systems, LLC ranks #702 out of 1,925 companies by total payment amount in the CMS Open Payments database for 2024.
What is the average payment size from Aesculap Implant Systems, LLC? ▾
The average transaction from Aesculap Implant Systems, LLC was $3.0K in 2024. The company made 222 total transactions to 222 recipients.
Where does the payment data for Aesculap Implant Systems, LLC come from? ▾
This data comes from the CMS Open Payments program (Sunshine Act), which requires pharmaceutical and medical device companies to report payments and transfers of value to physicians and teaching hospitals. The data covers Program Year 2024.

Data Source: Centers for Medicare & Medicaid Services (CMS) Open Payments, Program Year 2024. Data includes general payments, research payments, and physician ownership/investment interests as required by the Physician Payments Sunshine Act. Total industry payments: $13.9B across 1,925 companies.

Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch Editorial
Disclaimer

This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

View saved (companies)
Download Aesculap Implant Systems, LLC's data (CSV)
Embed this widget

Copy this snippet to embed a live-linked card on your own site.

Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-25.